[The epidemiology of multiple myeloma].

Abstract

We investigated epidemiology of multiple myeloma (MM), referring to recent papers. This article includes three points: 1) the progression rate of monoclonal gammopathy of undetermined significance (MGUS) to MM, 2) the effect of radiation to prevalence of MM, and 3) secondary malignancy after chemotherapy used to treat MM. The risk of progression from MGUS to MM is 1% per year. The researches of atomic bomb showed that there is no increase of risk of MM after radiation exposure. In contrast, studies investigating workers in nuclear power plants point out that radiation exposure over 50 mSv increases risk of MM. The incidence of secondary malignancy after chemotherapy used to treat MM was about 5%. This article will help to review recent researches about epidemiology of MM.

• Authors: Kenshi Suzuki, Haruka Takahashi
• Journal: Nihon rinsho. Japanese journal of clinical medicine (Nihon Rinsho) Vol. 73 Issue 1 Pg. 7-12 (Jan 2015) ISSN: 0047-1852 [Print] Japan
• PMID: 25626296 (Publication Type: English Abstract, Journal Article, Review)

Topics

• Age Distribution
• Humans
• Multiple Myeloma (epidemiology, etiology)
• Neoplasms, Radiation-Induced
• Neoplasms, Second Primary (chemically induced)
• Paraproteinemias (complications)
• Prevalence
• Risk Factors